AU2002359333A1 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins

Info

Publication number
AU2002359333A1
AU2002359333A1 AU2002359333A AU2002359333A AU2002359333A1 AU 2002359333 A1 AU2002359333 A1 AU 2002359333A1 AU 2002359333 A AU2002359333 A AU 2002359333A AU 2002359333 A AU2002359333 A AU 2002359333A AU 2002359333 A1 AU2002359333 A1 AU 2002359333A1
Authority
AU
Australia
Prior art keywords
nucleic acid
associated proteins
proteins
nucleic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359333A
Other languages
English (en)
Inventor
Shanya D. Becha
Mark L. Borowsky
Neil Burford
Narinder K. Chawla
Vicki S. Elliott
Brooke M. Emerling
Ian J. Forsythe
Kimberly J. Gietzen
Ann E. Gorvad
Jennifer A. Griffin
April J. A. Hafalia
Craig H. Ison
Preeti G. Lal
Ernestine A. Lee
Sally Lee
Soo Yeun Lee
Joseph P. Marquis
Jayalaxmi Ramkumar
William W. Sprague
Anita Swarnakar
Y. Tom Tang
Bridget A. Warren
Junming Yang
Henry Yue
Yeganeh Zebarjadian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002359333A1 publication Critical patent/AU2002359333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
AU2002359333A 2001-10-29 2002-10-29 Nucleic acid-associated proteins Abandoned AU2002359333A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US34844201P 2001-10-29 2001-10-29
US60/348,442 2001-10-29
US33554401P 2001-11-01 2001-11-01
US60/335,544 2001-11-01
US33753501P 2001-11-05 2001-11-05
US60/337,535 2001-11-05
US34465001P 2001-11-09 2001-11-09
US60/344,650 2001-11-09
US33476201P 2001-11-15 2001-11-15
US60/334,762 2001-11-15
PCT/US2002/034846 WO2003038052A2 (fr) 2001-10-29 2002-10-29 Proteines associees aux acides nucleiques

Publications (1)

Publication Number Publication Date
AU2002359333A1 true AU2002359333A1 (en) 2003-05-12

Family

ID=27541124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359333A Abandoned AU2002359333A1 (en) 2001-10-29 2002-10-29 Nucleic acid-associated proteins

Country Status (5)

Country Link
EP (1) EP1497315A2 (fr)
JP (1) JP2005508636A (fr)
AU (1) AU2002359333A1 (fr)
CA (1) CA2462660A1 (fr)
WO (1) WO2003038052A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004528046A (ja) * 2001-06-05 2004-09-16 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＤＧＫｓおよび使用方法
EP1880005B1 (fr) * 2005-05-13 2012-11-07 Centre National de la Recherche Scientifique Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
GEP20156313B (en) 2010-09-22 2015-07-10 Alios Biopharma Inc Substituted nucleotide analogs
EP2794630A4 (fr) 2011-12-22 2015-04-01 Alios Biopharma Inc Analogues de nucléotide phosphorothioate substitués
CN104321333A (zh) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 硫代氨基磷酸酯核苷酸前药的固体形式
WO2013142157A1 (fr) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Combinaisons pharmaceutiques comprenant un analogue thionucléotidique

Also Published As

Publication number Publication date
EP1497315A2 (fr) 2005-01-19
WO2003038052A2 (fr) 2003-05-08
JP2005508636A (ja) 2005-04-07
CA2462660A1 (fr) 2003-05-08
WO2003038052A3 (fr) 2004-11-11

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2003232086A1 (en) Nucleic acid-associated proteins
AU2002358273A1 (en) Nucleic acid-associated proteins
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2003217992A1 (en) Nucleic acid-associated proteins
AU2002359333A1 (en) Nucleic acid-associated proteins
AU2002355292A1 (en) Nucleic acid-associated proteins
AU2002345422A1 (en) Nucleic acid-associated proteins
AU2002343043A1 (en) Processing nucleic acid
AU2002326372A1 (en) Nucleic acid-associated proteins
AU2002326332A1 (en) Nucleic acid-associated proteins
AU2002364926A1 (en) Nucleic acid-associated proteins
AU2002256065A1 (en) Nucleic acid-associated proteins
AU2002256993A1 (en) Nucleic acid-associated proteins
AU2002365595A1 (en) Nucleic acid-associated proteins
AU2002258520A1 (en) Nucleic acid-associated proteins
AU2002326641A1 (en) Nucleic-acid associated proteins
AU2003269922A1 (en) Nucleic acid-associated proteins
AU2002324915A1 (en) Nucleic acid-associated proteins
AU2002232822A1 (en) Nucleic acid-associated proteins
GB0117193D0 (en) Protein modification reagents
AU2001297737A1 (en) Nucleic acid-associated proteins
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2002329425A1 (en) Dna sequencer
AU2002357873A1 (en) Carbohydrate-associated proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase